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ABSTRACT 
 
Background: Pregnant women with opioid use disorder are a major concern to the healthcare 
industry. They are not only one of the most stigmatized groups but are in need of outreach. Women 
who are afflicted by opioid addiction are a highly vulnerable group who are at risk of adverse 
pregnancy outcomes and perinatal complications. The purpose of this study was to do a meta- 
synthesis of the literature to gain a better understanding of the women’s perspective who are 
addicted to opioid during pregnancy. 
Subjects and Method: We conducted an exhaustive literature search for qualitative studies that 
focused on women with opioid used disorder during pregnancy and postpartum. After conducting a 
rigorous methodological protocol for meta-synthesis described by Joanna Briggs Institute, ten 
studies met the criteria for inclusion into this study. We used the Qualitative Assessment and 
Review Instrument (QARI) from the Joanna Briggs Institute to assist with data management. We 
extracted the representative quotations and categorized them into like themes. 
Results: There were three themes formulated from this meta-synthesis: overarching fear, trust 
and educational deficits. This meta-synthesis of qualitative studies leads to greater understanding 
of how pregnant women with opioid use disorder perceive the consequences of their actions. 
Conclusion: Implications from this meta-synthesis will inform those working with opioid 
addicted pregnant women and aid in establishing best practices for them and their infants by 
revealing their addiction experiences and narratives. 
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BACKGROUND 
Opioid use disorder (OUD) is a problematic 
pattern of opioid use that causes significant 
impairment or distress (Center for Disease 
Control and Prevention [CDC], 2017). In the 
United States, the opioid addiction has 
increased to the point of being a public 
health crisis (Kaiser Family Foundation 
[KFF], 2018). Addiction is no longer in the 
back streets with substances such as heroin, 
but now anyone who has the ability to obtain 
prescription opioids such as oxyco- done 
and hydrocodone has the potential of 
becoming addicted. As many as 1.7 million 
people have an addiction to prescription 
opioids as compared to 626,000 heroin- 
addicted individuals (KFF, 2018). In some 
areas, up to 40% of Medicaid, non-elderly 
patients are addicted to opiates (KFF, 2018). 
Deaths from opioid overdoses are highest 
among white, non-Hispanic males. Black, 
non-Hispanic males have the second highest 
death rate from opioid overdose. Hispanic 
men have the lowest rate. Even though men 
have the highest rate of deaths from opiate 
overdose, the rate of opioid use is growing in 
women, and in 2016, the female death rate 
was 8.5 deaths per 100,000 women (KFF, 
2018). 
Many abusers/addicts become depen- 
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dent after having a prescription for pain 
medication for an injury or surgery. The 
medication creates artificial neurotrans- 
mitters   that   act   on   the   dopamine   and 
endorphin sensors in the brain causing 
pleasure and euphoria. After continued use 
of the medication, the body can no longer 
produce these sensations on its own, and the 
medication is needed in larger quan- tities to 
cause the euphoria previously felt (National 
Institute on Drug Abuse [NIDA], 2014). 
Hallmarks of the disorder are decreased 
sensitivity to use, being pre- occupied with 
wanting to use the drug, feeling helpless to 
control these feelings, and ambivalence to 
the negative conse- quences of the drug use 
(NIDA, 2014). 
Treatment for this addictive disorder 
can be difficult because there are many 
factors that motivate drug use. Abstinence 
only programs of rehabilitation have the 
highest rate of relapse (McHugh et al., 
2010). Combined therapy programs with 
support groups and behavioral  therapy have 
the best results in treating addictive dis-
orders (McHugh et. al, 2010). However, the 
elements impacting addicts is the chro- nic 
lack of accessible, quality treatment. 
Just as opioid use has dramatically 
increased in the general population, the rate 
of women becoming addicted has increased 
to nearly one third of those seeking addict-
ion care (Nordenfors and Höjer, 2017). 
Women are considered the primary child-
care provider from the moment they become 
pregnant through the early developmental 
years, hence, women who are addicted, 
especially if pregnant, are looked upon as 
more deviant and vilified to a greater extent 
than men (Nordenfors and Höjer, 2017; 
Watson and Parke, 2011). Pregnant women 
are turning to opioid use at a steadily 
growing rate, and women who are addicted 
are becoming pregnant (CDC, 2017). Neo-
natal abstinence syndrome (NAS) is a group 
of conditions that are caused when a baby 
has been exposed to drugs during 
pregnancy. NAS has increased from 1.5 cases 
per 1,000 hospital births in 1999 to  6.0  per  
1,000  hospital  births  in 2013 (NIDA, 
2015). States with increased NAS prevalence 
have high rates of opioid prescriptions. 
Treating NAS infants costs hospitals 
approximately 1.5 billion a year more than 
treating non-NAS infants; the majority of 
these charges (81%) are paid by state 
Medicaid programs (NIDA,  2015). For 
women diagnosed with opioid use disorder, 
it is challenging to manage the many aspects 
of their lives coupled with demands and 
pressure to adhere to healthy pregnancy 
practices (NIDA, 2015). 
Healthcare of pregnant women with OUD is 
difficult and best practices are important. 
The provider of care may not understand 
why any mother would self- administer 
opioids, and the provider may exhibit 
unconscious bias toward the mother. This 
article sought out research from the patient 
perspective with a plan to inform healthcare 
providers about opioid addicted pregnant 
women and their infants by revealing the 
woman’s addiction experiences and narra-
tives. Much research has focused on physio-
logic effects of maternal opioid use on fetal 
outcomes without taking into account the 
woman’s experience (Ross, 2015). Docu-
menting the mother’s percept- ions or moti-
vations is limited in scope and difficult to 
find. 
 
SUBJECTS AND METHOD 
 
1. Study design 
This systematic search strategy included 
qualitative studies that addressed the 
woman’s perspective of living with opioid 
use disorder while pregnant or early post- 
partum. Only qualitative studies with a 
patient perspective on the self-perceived 
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consequences or experiences of opioid use 
on pregnancy or early postpartum, including 
methods related to phenomenology, focus 
groups, action research, grounded theory, or 
ethnography were included. Quantitative 
outcome measures were not included. 
We obtained articles through a syste-
matic literature search of online databases. 
The databases included were PubMed 
(2007-2017),      PsychInfo      (2000-2017), 
CINAHL (2007-2017), EBSCO (1996-2017), 
and Ovid (2007-Current). The period 
reflects the previous 10 years, which is a 
period of rapid increase of opioid use. The 
search terms used included: “pregnancy”, 
“opioid addiction”, “perception”, “addiction” 
and “opioid addicted mothers” to seek out 
appropriate articles. The search terms were 
widely applied in order to obtain a robust 
result for qualitative articles. Inclusion 
criteria: the study must be printed in 
English; be a research study using a quali-
tative method; and be relevant to a woman’s 
perception or experiences of using opioid 
drugs in a way other than prescribed while 
pregnant or early post-partum. The authors 
found 303 articles through searching the 
databases. They reviewed the titles and abs- 
tracts of each study as a first pass to deter- 
mine if the study met the criteria. The 
authors obtained and evaluated twenty full 
text articles and excluded 13. We excluded 
two of the articles because they were quan-
titative rather than qualitative and the 
remaining were excluded because they did 
not focus on the women’s perceptions, but 
instead on fetal heart rate, addiction help, 
metabolic effects of addiction, or legal con- 
siderations. We performed a backward 
search of the references by hand and found 
seventeen potential articles. Out of these, we 
added three additional articles (Figure 1). 
2. Data extraction 
After a final review, ten articles matched the 
inclusion criteria for this review (See Table 
1). The authors reviewed and critically 
evaluated each of the ten included quali- 
tative articles by answering a series of 
standard evaluation questions developed by 
the Joanna Briggs Institute. The authors 
compared appraisals, and the authors 
reached congruence before entering the data 
into the Qualitative Assessment and Review 
Instrument (QARI), an online assessment 
tool provided by the Joanna Briggs Institute. 
We used this assessment to evaluate each 
study and determine its credibility, quality, 
and whether it should be ultimately 
included. Once the authors determined 
inclusion, they used the QARI instrument to 
assist in determining the findings, deve-
loping themes, and produce synthesized 
findings. In order to justify credibility, the 
authors confirmed that the data supported 
the developed themes. 
 
RESULTS 
 
The authors identified sixteen findings and 
categorized them into seven themes. The 
seven themes were meta-synthesized into 
three synthesized findings. The three syn- 
thesized findings were Overarching Fear, 
Trust, and Educational Deficits. 
Overarching Fear 
The synthesized finding of Overarching 
Fear included three themes: Fear of 
Repercussion, Internal Ambivalence, and 
Stigma (See Figure 2). 
Fear of repercussion. The women who 
were addicted to opioids feared authority 
figures that kept many women from seeking 
treatment. If they were in prenatal care or 
when they went into the hospital for deli- 
very, they felt powerless regarding their 
care. Women feared that if they gave birth or 
sought out help in a hospital setting, 
authorities would take their child away.  
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Explicit decisions Implicit decisions 
 
 
 
 
 
 
 
 
Figure 1. Article Decisions 
 
Providers sent many women to treatment 
centers, and the women did not have any 
options about the treatments. One woman 
stated, “I was given no option. If you with-
draw you die…stay on methadone or we’re 
going to call CPS on you” (Howard, 2016). 
Fear of child protective services (CPS) was 
very real for addicted women. They felt like 
they were being watched, and if they stepped 
out of line, CPS would detox at home by 
myself so I would’t have to have a baby born 
that has withdrawals (Howard, 2016). An-
other woman found that she was “kidnap” 
they baby after delivery. 
Internal ambivalence. Women who were 
addicted to opioids can have many ambi-
valent feelings. They may be ambivalent 
towards their pregnancy and wonder if they 
should continue the pregnancy. Many 
woman did not have the monetary means to 
choose an abortion. If they kept the preg-
nancy, there was ambivalence between 
continuing the addiction and concern for 
how the opioids would affect the pregnancy. 
Excluded: #32 studies 
Articles excluded because they were not about 
pregnancy, were not from the maternal 
perspective, or did not include qualitative 
methods 
Kept: #1 
EBSCO 2007-2017 
Total=#33 
 
Limiters: pregnancy, opioid addiction, 
perception, opioid addiction mothers 
Ovid 2007-2018 Total=142 
Limiters: pregnancy, opioid addiction, 
perception, opioid addiction mothers 
Total of 7 articles retained 
Excluded: 139 studies 
Articles excluded because they were not about 
pregnancy, were not from the maternal 
perspective, or did not include qualitative 
methods 
Kept: #3 
Excluded: #20 studies 
Articles excluded because they were not about 
pregnancy, were not from the maternal 
perspective, or did not include qualitative 
methods 
Kept: #2 
CINAHL 2007-2017 Total=#22 
Limiters: pregnancy, opioid addiction, 
perception, opioid addiction mothers 
Excluded: #13 studies 
Articles excluded because they were not about 
pregnancy, were not from the maternal 
perspective, or did not include qualitative 
methods 
Kept:  #0 
PsychInfo 2007-2017 Total=#13 
Limiters: pregnancy, opioid addiction, 
perception, opioid addiction mothers 
Excluded: #92 studies 
Articles excluded because they were not about 
pregnancy, were not from the maternal 
perspective, or did not include qualitative 
methods 
Kept:  #1 
PubMed 2007-2017 Total=#93 
Limiters: pregnancy, opioid addiction, 
perception, opioid addiction mothers 
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“I didn‟ t know what to do. I felt I 
couldn‟ t stop taking drugs, how could I be a 
good mother? Afterwards, I could see things 
more clearly: I could stop it for this child. 
My baby would save me and it gave me 
strength enough to carry on (Silva et al., 
2012).” 
Figure 2. Hierachy of Themes 
Feelings of powerlessness 
 
External pressure 
and control 
 
Fear of CPS 
 
Ambivalence toward 
Pregnancy 
Fear of the Effects on Fetus 
Stigma 
Support 
Not being judged 
Not given options 
in treatment 
Fear of 
Repercussion 
Overarching Fear 
Internal 
Ambivalence 
Struggle between Addiction 
and Responsibility to 
Pregnancy 
Fear of Judgement 
 
Self-Judgement, self-hatred, 
shame and guilt 
 
Gaining Trust is difficult 
Mistrust Vulnerability 
Trust 
Trust is lost when CPS 
contacted 
Assurance 
Availability of Nurses and 
resources 
Women lack 
understanding about 
addictions 
Addictions are fast and hold 
power 
Educational Deficits 
Nurses lack understanding 
& empathy 
Journal of Maternal and Child Health (2019), 4(6): 461-473 
https://doi.org/10.26911/thejmch.2019.04.06.07 
 
466   e-ISSN: 2549-0257 
Table 1. Articles used in review 
 
Title Authors Participants Method Data collection Findings 
Substance, structure and stigma: 
Parents in the UK accounting for opioid 
substitution therapy during the ante-
natal and Postnatal periods (2013) 
Chandler A, Whittaker 
A, Cunningham-Burley 
S, Williams N, Mc-
Gorm K, Mathews G 
Purposive sample of 19 
opioid dependent 
service workers (15 
women, 4 men) 
Analyzed thema-
tically using cons-
tant comparison 
Longitudinal data 
was collected by 3 
semi-structured 
interviews 
Participants were currently in an opioid substitution therapy 
(OST) program. Themes included: OST as a facilitator of normal 
parenthood; OST as a barrier to normal family life 
Experiences of Mothers of 
Infants with NAS in the 
NICU (2014) 
Cleveland LM, Bonugli 
R 
15 Hispanics Sub-
stance addicted 
mothers of infants with 
NAS 
Qualitative 
Content analysis 
Semi-structured 
individual inter- 
views 
4 themes: understanding addiction; watching the infant 
withdraw; judging; trusting the nurses 
“Try not to judge.” Mothers of substance 
of exposed infants (2013) 
Cleveland LM, Gill SL 5 women on metha-
done between the age 
of 22-37 
Qualitative content 
analysis 
Semi-structured 
interviews 
4 themes: “try not to judge,” “scoring” the baby, “share with me,” 
and “I’m the mother here! 
Mothers’ experience of methamphetamine 
addiction: A case-based analysis of 
rural, Midwestern women (2009) 
Haight WL, 
Carter- 
Black JD, Sheridan K 
4 rural, white, single 
women in their 30s, in 
recovery from 
methamphetamine 
addiction 
Description of 
cases Constructed 
through Multiple 
readings of 
Transcripts 
Face to face, semi-
structured inter-
views 
“When you get sober, you get a heart again;” “This is a whole 
different world;” “drugs were more powerful than the love for my 
kids;” “You still had responsibilities…until you don’t see the point 
in it anymore;” 
Experience of opioid-dependent women 
in their prenatal and postpartum care: 
implications for social workers in health 
care (2016) 
Howard H 30 English speaking 
women 
within 6 months of 
delivery 
Interpretive 
phenomenology 
Group interviews 
of postpartum 
women 
Decision making about treatment choices during pregnancy; 
Reflections on treatment decisions by health care providers; fear 
of separation from their infants; feeling under surveillance 
Mothers with substance 
and alcohol abuse— 
support through pregnancy 
and early infancy (2017) 
Nordenfors M, Höjer I 17 women between the 
ages of 21-40, 
Qualitative 
Content 
analysis 
Individual semi- 
Structured inter-
views 
Themes: initial ambivalence to the pregnancy; frequent contact 
and control; availability; a holistic perspective; trusting 
relationships; 
not being judged; a 360° turn;  
Balancing motherhood and drug 
addiction: The transition to parenthood 
of addicted mothers (2012) 
Silva SA, Pires AP, 
Guerreiro C, Cardoso A 
24 drug addicted 
mothers on methadone 
with ages 25-42 and 
children 1-32 months 
of age 
Grounded Theory Semi-Structured 
interviews 
Circumstances for substance abuse during pregnancy; 
Ambivalence between addiction and pregnancy/parenting; 
Functional (minimal) parenting; Intervening factors: family 
support to parental role 
Beliefs and behaviors of pregnant 
women with addictions awaiting 
treatment initiation (2017) 
Van Scoyoc A, 
Harrison JA, Fisher PA 
15 women who were 
either pregnant or 
postpartum who had 
used illicit substances 
during pregnancy 
Grounded Theory Semi-Structured 
Interviews 
4 Categories: Beliefs about the negative impact on the baby of 
substance use during pregnancy; 
Seeking information about the impact of substance use; 
Reducing substance use prior to accessing treatment services; 
Engaging in health promoting behaviors 
Experience of recovery for female heroin 
addicts: An interpretive pheno-
menological analysis (2011) 
Watson L, Parke A 5 Female heroin 
addicts 
Interpretive 
phenol- Menolo-
gical analysis 
Open ended, semi-
structured 
interviews 
Super-ordinate themes: Childhood experiences; physiological 
and physiological and psychological effects; and perceptions of 
recovery  
Methadone, buprenorphine and 
preferences for opioid agonists 
treatment: A qualitative analysis 
(2016) 
Yarborough BJH, 
Stumbo SP, McCarty 
D, Mertens J, Weisner 
C, Green CA 
Adults with opioid 
dependence (238) 
Coded using Atlas. 
ti 
Interviews, audio-
recorded, trans-
cribed verbatim 
Awareness of treatment options; expectations and goals for 
duration of treatment and abstinence; prior experience; need for 
accountability; preference to avoid methadone clinics; fear of 
continued addiction; pain control 
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Many women experienced feelings of 
anxiety, depression, and even had panic 
attacks.  One woman said that her “heart 
would beat fast, it races like mad, then I get 
this feeling like I’m in trouble, and I’ve 
done nothing wrong. It happens at night, 
you know, when I’m laid in bed, and I think 
why I am worrying? (Watson and Parke, 
2011).” Women without social support 
experienced more ambivalence. Even if 
they were in a drug treatment facility, 
there was fear of how methadone or Sub-
oxone would affect the pregnancy. One 
woman stated, I had only been back on the 
methadone for, like, 3 weeks when I found 
out that I was pregnant. So mainly I was, 
like, scared and mad, like I wish I would’ve 
known 3 weeks ago (that I was pregnant), 
because I just wouldn’t have gotten back on 
it, I would have just sucked it up, and, you 
now, did the detox at home by myself so I 
wouldn’t have to have a baby that has 
withdrawals (Howard, 2016). 
Another woman found out she was 
pregnant while on methadone, and felt that 
“at least it was the lesser of two evils 
(Chandler et al., 2013).” The women fear-
ed that what they were doing would affect 
their infants. They did not want to watch 
their infants withdraw from what they had 
put in their bodies. They described shame 
and guilt for what they put their infants 
through, but they also voiced a helpless-
ness of being able to stop it (Cleveland and 
Bonugli, 2014). Although women described 
being able to make some positive changes, 
they also described struggling to decrease 
their use of substances they were depen-
dent upon and often making unsuccessful 
attempts to quit (Van Scoyoc, 2017).“Fear. 
Fear, in the end, I’d say, my rock bottom 
was fear (Watson and Parke, 2011).” 
Stigma. Addicted women described 
feelings of self-judgement, self-hatred, 
shame, and guilt when talking about their 
addictions and the effects on their infants. 
One woman said, “I know it’s my fault, but 
she should’t have to suffer because of 
things I chose to do (Cleveland and 
Bonugli, 2014).” Another said, “I did bad. I 
hurt him, you know? If it wasn’t for my 
drug use, my stupidity, he wouldn’t be 
going through this. I put him through 
this…I put him in that situation (Cleveland 
and Bonugli, 2014).” The women spoke 
about being incapable of control, stating 
that no drug addict would be able to keep 
from using the drugs, thus relieving them of 
their responsibility (Silva et al., 2012). 
Others felt it would be better for them and 
their pregnancy/infants to remain on a 
stable dose then to try to wean off the drugs 
(Chandler et al., 2013). The drugs con-
sumed their lives, and they had little room 
left for being mothers. 
The women felt judged by the pro-
viders, doctors and nurses, when the 
women went to appointments or were in 
the hospital. Many times the women felt as 
though the nursing staff negatively judged 
them because of their history of drug use. “I 
would be watched whenever I was holding 
my baby (Cleveland and Gill, 2014).” One 
NICU nurse called an addicted mother a 
“junkie mom” (Cleveland and Bonugli, 
2014). Another said, “the nurses would be 
rolling their eyes…It made me feel ugly 
(Cleveland and Gill, 2013, p. 203).”Some 
women felt that they deserved judgement 
because of what they had done to their 
infants, as long as the nurses treated their 
infants correctly (Cleveland and Bonugli, 
2014). 
Trust 
The synthesized finding of Trust included 
two themes: Mistrust and Assurance. 
Mistrust. Women with opioid addictions 
had difficulty with trust. They had 
experienced the fear, ambivalence, and 
stigma that described above. They had 
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difficulty trusting themselves, and if they 
could not trust themselves, it was not 
possible to trust others. They worried that 
the health providers around them would 
contact authorities about them—police 
regarding their addiction, or CPS to come 
and take the infant. The women did not 
want anyone to come and take the infant 
out of the room fearing they may never 
see the infant again (Watson and Parke, 
2011). Many women participated in treat-
ment programs just so they could retain 
custody of their child/ children. One 
mother stated that she was replacing her 
addiction for heroin with an addiction for 
methadone in order to keep her infant 
(Chandler et al, 2013). 
Assurance. There are programs for 
addicted pregnant women, or women with 
young infants that provide support for the 
women with a holist perspective. The health 
providers provide a trusting relationship 
and collaborate with the woman throughout 
her pregnancy. The women viewed the 
nurses as caring when they took the time to 
communicate on a personal level. “She 
would share her life with me…She knew 
something about me and I knew something 
about her (Cleveland and Gill, 2013).” Some 
programs provide women with counseling 
regarding parenthood, and addiction. They 
show respect to the women.  One  woman 
stated,  “They  show  respect  for  what  you 
have  experienced,  they  are  understanding 
(Nordenfors and Höjer, 2017).” Another 
woman stated, “It was not like, you are a 
bad person, you have led a bad life and now 
we have to control you,‟ not at all. They had 
a positive attitude, which I really appre- 
ciated (Nordenfors and Höjer, 2017).” 
Educational Deficits 
The synthesized finding of Educational 
Deficits included two themes: Nurses not 
truly understanding addictions and little 
understanding about addictions. 
Nurses do not truly understand 
addictions. In reviewing the chosen 
articles, the articles made it clear that there 
was a pervasive perception of stigma 
presented to the women. The women did 
not feel that the nurses understood what 
the women were experiencing (Howard, 
2016). “I felt judged. I felt like the nurses 
thought of me as a drug user and that was 
my whole life story (Cleveland and Bonugli, 
2014).” This strained relationships between 
the nurses and the mothers, leaving the 
mothers feeling judged by the nurses. 
Little understanding about addiction. 
There was understanding about the statis-
tics of opioid dependence in pregnancy, but 
there was little understanding of how 
quickly an addiction can occur in a woman‟ 
s life and the power it could hold over her 
life. “It got out of control—fast… you’re 
extremely paranoid when you’re on meth. 
…you don’t think rationally. It’s all 
about you, you, you (Haight et al., 2009).” 
There is no woman ever who goes out to 
become addicted on pain relievers, tranqui-
lizers, stimulants and sedatives. The stereo-
type of the addicted woman in the back alley 
buying drugs is not an accurate picture. No 
educational level, social class, or residential 
location can protect a woman from opioid 
addiction. 
Opioid use in pregnancy is associated 
with a risk of neonatal abstinence syn-
drome (NAS) which results in neonatal 
morbidity, irritability, feeding difficulty, 
emesis, loose stools, respiratory distress 
and other difficulties. Many addicted 
women not only use opioid drugs, but 
frequently smoke cigarettes, drink alcohol, 
and marijuana, compounding the substance 
exposure to the infant (Forray, 2016). 
While there is a want for knowledge 
exhibited by many opioid-addicted preg-
nant women, the knowledge received is 
often times unreliable, inaccurate, and 
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incomplete. In correlation to the fear of 
effects identified within the population, 
most women want knowledge about their 
addictions. Women often “sought infor-
mation about the effect of their substance 
use during pregnancy on the developing 
infant” and that “women reported reading 
information in books, talking with friends, 
talking with parents, and learning about the 
outcomes associated with prenatal exposure 
during prenatal appointments (Van Scoyoc, 
2017).” 
When asked about effects of opioid 
abuse on the fetus, many mothers refe-
renced peers and the perceived effects drug 
use had in different situations. In one 
quoted several different women as saying 
very similar things regarding their own 
personal observations regarding drug use 
on the fetus. One woman stated,  
If they’ve used meth their whole 
pregnancy, I ‘ve heard that and seen 
actually some babies are born with, you 
know, their ears could be folded down a 
little, or their eyes, they could have 
trouble with their eyes. You know, clubbed 
foot. I mean I’ve seen it and I’ve heard it 
(Van Scoyoc, 2017).  
Another woman stated, 
My [friend] did a lot of pills and 
alcohol and had a baby…he was like six 
months old and couldn’t eat on his own and 
it was due to drugs and alcohol. He has a 
feeding tube for the rest of his life and he 
can’t really talk to you (Van Scoyoc, 2017). 
Mothers reported seeing and hearing 
of children with defects attributed to drug 
use. This speculation aided in the growth of 
fears, as well as internal stigma, within 
these mothers (Van Scoyoc, 2017). 
In addition to peers, women often 
reported spending time on the Internet 
trying to find information about the effect 
of drug use on their child. One woman said 
that she spent up to 70 hours on the 
Internet researching and would simply read 
over the same things over again. The 
women who reported using the Internet for 
research did “goal driven” research; their 
goal was to find the impact of drug use on 
the fetus. One woman in particular stated 
that she wanted to know if the fetus was 
high in her body. Other women tried to find 
facts backing up their drug use, such as 
opioid use having no specific harmful 
effects on the fetus (Van Scoyoc, 2017). 
 
DISCUSSION 
We identified Overarching Fear, Trust, and 
Educational Deficits as the synthesized 
findings in this review. Most addicted 
women suffer from low self-esteem, social 
isolation, and are vulnerable. They place 
their health and the health of their infants 
in the hands of the nurses, and the women 
are scared (Watson and Parke, 2011). 
Women come to expect victimization in so 
many areas. Women, who were addicted to 
opioids, fear stigma related to feelings of 
judgment from the nurses and providers 
who cared for them and their infants. These 
mothers need emotional support, but 
support is not always received (Cleveland, 
2008). Many of the women interviewed in 
the various articles discussed how the 
nurses and providers judge and blame 
them. The American Nurses Association is 
very clear in the Code of Ethics for Nurses 
that nurses should “practice with com- 
passion and respect for the inherent dig-
nity, worth, and unique attributes of every 
person (Provision 1, ANA Code of Ethics for 
Nurses, 2015).” This provision encompasses 
respect for human dignity, establishing a 
relationship of trust and providing nursing 
services according to need, and respecting 
the dignity and rights of all human beings 
regardless of the factors contributing to the 
person‟ s health status, and right to self- 
determination (Provision 1, ANA Code of 
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Ethics for Nurses, 2015). 
Throughout all of the studies review-
ed, it was alarmingly clear that many 
women have a lack of knowledge of the 
effects of drug use on themselves, their 
fetus, and how quickly one can fall into 
addiction. One woman said that “drugs 
were more powerful than the love for her 
children…and [then she would use the 
drug] to get rid of the shame and guilt for 
what I was feeling…I had low self-esteem…I 
gave up hope (Haight et al., 2009).”  The 
literature describes the quickness with 
which the woman becomes obsessed with 
the drug and how the drug becomes more 
important than anything else in their life— 
even their children (Haight et al., 2009). 
They lose their ability to think rationally. 
The addicted women in this review 
were very worried about what they had 
done to their infants. They felt guilt and 
self-shame over the effects of their drug use 
on their infants. This made information 
regarding their infant all the more import- 
ant. Some women felt that the NICU 
personnel excluded them from the care of 
their infants because of their addiction, or 
they did not receive accurate or complete 
information regarding their infant’s condi-
tion. Approaches that encourage the 
mothers to participate in their infants’ care, 
treating the mothers with respect, and 
maintaining an active, informative dialogue 
added the ability for the mothers to build 
trust with the nurses (Cleveland, 2008). 
The women also wanted to have 
options within their own addiction treat-
ment, as well as patient education and 
patient-provider communication. Without 
these, they had difficulty trusting, felt 
judged and were vulnerable. Yarborough 
and colleagues (2016) corroborated these 
feelings in their article. They found that 
when there was better collaboration, 
improved education, and partnership in 
addiction treatment decisions, the patients 
were more likely to remain in treatment 
(Yarborough et al., 2016). 
Implications for Providers 
Providers can aide in reducing stigma, 
building trust and helping educate mothers. 
Healthcare providers need education to 
understand women with addictions. Edu-
cation should include physiological aspects 
of opioid addiction so that practitioners and 
nurses know more about withdraw and how 
to   properly   detoxify   pregnant   women. 
Without proper knowledge, provi-
ders may come across negatively to the 
mother. Focused sessions about health-
care help to reduce stigma and decrease 
an addicted women’s fears. Educational 
sessions and online modules highlighting 
the thoughts and feelings of pregnant 
women who are addicted to opioids are 
ways to provide education. Practicing 
unbiased, active listening sessions help to 
reduce stigma. 
This encourages mothers to speak 
openly about their addictions and the 
barriers they are facing. Active listening 
also promotes trust in the nurses, and other 
healthcare providers, by making mothers 
feel heard and cared for. Nurses should also 
create positive-nurse patient relationships 
pro- mote trust, as it is a key aspect in the 
process of reducing stigma. If mothers feel 
they can trust healthcare providers, they 
are more likely to reach out for help. 
Healthcare providers should treat each 
woman as an individual. As each woman is 
an individual, each addicted woman is also 
an individual and will have individual 
needs. 
Education for the addicted woman is 
a key. By providing outreach without jud-
gement to women who use opioids, health 
care providers increase the mothers‟ trust 
in the healthcare system, making them 
more likely to reach out for help when they 
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become pregnant. This may be a simple 
patient education that occurs during an 
exam or in a group setting. This allows 
women to ask questions and receive feed- 
back. Pamphlets or other written infor-
mation may also be beneficial in promoting 
education. Written information allows 
women to have information to look back on 
and read when they cannot be with a 
healthcare provider to ask questions. Edu-
cation should include the effects of opioids 
on the fetus, ways to stop opioid use, and 
how to best manage withdrawal symptoms. 
Healthcare providers should know 
where and how to access treatment 
centers that provide medications to lessen 
withdrawal symptoms and provide support 
groups. Physical and psychological mana-
gement of withdrawal symptoms make 
withdrawal seem less daunting and more 
manageable. Pregnant women need better 
treatment care for withdrawal as many 
standard treatments cause harm to the 
fetus. Better treatment for withdrawal also 
increases rates at which women try to dis-
continue drug use, because the withdraw-
al process seems less daunting and physi-
cally demanding. All of these implications 
should be used together to promote the best 
results for mothers with opioid addiction. 
Limitations 
There is a paucity of research on this topic 
and the number of women becoming 
addicted to opioids is growing by astro-
nomical numbers. Many of these women 
will be in their childbearing years, which 
increased the likelihood of pregnant women 
with addictions and the number of infants 
born addicted. 
This review was limited by the in-
ability to find articles that were specific to 
our topic of understanding the experiences 
of the addicted mothers during pregnancy 
and early postpartum and how it relates to 
nursing. 
Potential for Future Study 
Study regarding the differences between 
opioids and medications used in treatment, 
such as methadone, suboxone, and others 
and their effect on pregnancy and post- 
partum. The women in this review talked 
about how the drug was stronger than their 
love for their children, yet, they feared that 
their children would be taken away. How 
do we keep women from becoming addict-
ed? How do we get women off opioids 
during pregnancy and keep them off after 
delivery so that   they   can   take care of 
their children? The answer is not just to 
fix the women. Healthy women come from 
healthy neighborhoods and communities. 
The answer comes in fixing the neighbor-
hoods and communities in which they live. 
In an editorial reflection by Arrowood 
(2016), she describes a newly postpartum 
mother attempting to deal with her infant 
who is inconsolable due to withdrawing 
from whatever substances the woman has 
consumed during pregnancy. Instead of 
approaching this young woman in a re-
proachful and judgmental tone, she instead 
enters the room and offers this new mother 
several techniques for quieting a hyper- 
sensitive child. She shows her how to 
swaddle the child and rock slowly. With this 
gentle movement, the baby quiets as the 
mother whispers her love to the child. It is 
possible that as this nurse develops a 
rapport with this new mother, that the 
nurse may also encourage the woman in her 
own treatment (Arrowood, 2016). 
A meta-synthesis of qualitative study 
allowed for greater understanding of how 
pregnant women perceive the consequences 
of their opioid use. This synthesized review 
included ten articles that were critically 
appraised and synthesized following a 
rigorous methodology. Limitations for this 
study exist in regard to the low number of 
qualifying studies. Many mothers who were 
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interviewed were interviewed after their 
pregnancy, so there statements are reflect- 
ions of the past. Nurses should make an 
increased effort to help reduce the stigma 
towards pregnant women with opioid use 
disorder. Pregnant women can benefit 
when nurses are informed about opioid use 
disorder. With increasing rates of opioid 
use during pregnancy, it is necessary for 
nurses to know how to care best for patients 
with opioid use disorder in order to provide 
the best care for the woman and her baby. 
 
AUTHORS CONTRIBUTION 
Deborah Stiffler, Mia Amundson, Lauren 
Hapke, Emilie Harvey, Samantha Sizemore, 
and Savannah Smith collected and selected 
the articles, proceeded data analysis, and 
wrote the manuscript. 
 
FUNDING AND SPONSORSHIP 
This study used the authors’ independent 
fund. 
 
CONFLICT OF INTEREST 
 
 
None of the authors have any disclosures to 
declare. 
 
REFERENCE 
 
 
Arrowood GL (2016). Inside the eyes of a 
mother with addiction. Nursing for 
Women’s Health, 20(5): 522524. 
Chandler A, Whittaker A, Cunningham- 
Burley S, Williams N, McGorm K, 
Mathews G (2013). Substance, struc-
ture and stigma: Parents in the UK 
accounting for opioid substitution 
therapy during the antenatal and 
postnatal periods. International Jour-
nal of Drug Policy, 24(6): e35e42. 
CDC (2017). Opioid Overview. Retrieved 
from https://www.cdc.gov-/drugover-
dose/data/index.html  
Cleveland L (2008). Parenting in the Neo-
natal Intensive Care Unit. Journal of 
Obstetric, Gynecologic & Neonatal 
Nursing, 37(6): 666691. 
Cleveland L, Bonugli R (2014). Experiences 
of Mothers of Infants with Neonatal 
Abstinence Syndrome in the Neonatal 
Intensive Care Unit. Journal of Obs- 
tetric, Gynecologic & Neonatal Nurs- 
ing, 43(3): 318329. 
Cleveland L, Gill S (2013). Try Not to 
Judge. MCN, the American Journal of 
Maternal/Child Nursing, 38(4), 
200205. 
Forray A (2016). Substance use during 
pregnancy. F1000 Research, 5: 887. 
Huang C, Lee I (2008). The first-three 
years of parenting: Evidence from the 
Fragile Families and Child Well 
Being Study. Children and Youth 
Services Review, 30(12): 14471457. 
Haight WL, CarterBlack JD, Sheridan K 
(2009). Mothers experience of 
methamphetamine addiction: A case- 
based analysis of rural, Midwestern 
women. Children and Youth Services 
Review, 31: 71-77. 
Howard H (2015). Experiences of opioid- 
dependent women in their prenatal 
and postpartum care: Implications for 
social workers in health care. Social 
Work in Health Care, 55(1): 6185. 
Kaiser Family Foundation [KFF] (2018). 
Medicaid’s role in addressing the 
opioid epidemic. https://www.kff.org-
/infographic/medicaidsroleinadd
 ressingopioidepidemic/. 
McHugh R, Hearon B, Otto M (2010). Cog- 
nitive behavioral therapy for substan- 
ce use disorders. Psychiatric Clinics of 
North America, 33(3): 511525. 
National Institute on Drug Abuse [NIDA]. 
(2014). America’s addiction to opio-
ids:  Heroin and prescription drug 
abuse. Retrieved from: https://www-
Stiffler et al./ Understanding pregnant women with opiod use disorder 
e-ISSN: 2549-0257   473  
.drugabuse.gov/aboutnida/legislati-
veactivities/testimonytocongress/
2016/americasaddictiontoopioids
heroinprescriptiondrugabuse. 
National Institute on Drug Abuse [NIDA]. 
(2015). Dramatic increases in mater- 
nal opioid use and neonatal abstinen-
ce syndrome. Retrieved from https:-
//www.drug-abuse.gov/relatedtopi-
cs/trendsstatistics/infographics/dra-
maticincreasesinmaternalopi-
oiduseneonatalabstinencesyn-
drome. 
Nordenfors M, Höjer I (2017). Mothers 
with substance and alcohol abuse- 
support through pregnancy and early 
infancy. Social Work in Health Care, 
56(5):  381399.   
Ross E, Graham D, Money K, Stanwood G 
(2014). Developmental consequences 
of fetal exposure to drugs: What we 
know and what we still must learn. 
Neuropsychopharmacology, 40(1): 
6187. 
Silva S, Pires A, Guerreiro C, Cardoso A 
(2012). Balancing motherhood and 
drug addiction: The transition to 
parenthood of addicted mothers. 
Journal of Health Psychology, 18(3): 
359367. 
Van Scoyoc A, Harrison J, Fisher P (2016). 
Beliefs and behaviors of pregnant 
women with addictions awaiting 
treatment initiation. Child and Ado-
lescent Social Work Journal, 34(1): 
6579. 
Watson L, Parke A (2009). Experience of 
recovery for female heroin addicts: An 
interpretative phenomenological ana-
lysis. International Journal of Mental 
Health and Addiction, 9(1): 102117. 
Yarborough BJH, Stumbo SP, McCarty D, 
Mertens J, Weisner C, Green CA 
(2016). Methadone, buprenorphine 
and preferences for opioid agonist 
treatment: a Qualitative analysis. 
Drug and Alcohol Dependence, 160: 
112118. 
 
 
 
 
  
 
 
 
